Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP502939.RAaG4A3rQJWHkKQaGt6Wmg4eLdFFztivI6oXWmRbAQ83Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP502939.RAaG4A3rQJWHkKQaGt6Wmg4eLdFFztivI6oXWmRbAQ83Q130_assertion type Assertion NP502939.RAaG4A3rQJWHkKQaGt6Wmg4eLdFFztivI6oXWmRbAQ83Q130_head.
- NP502939.RAaG4A3rQJWHkKQaGt6Wmg4eLdFFztivI6oXWmRbAQ83Q130_assertion description "[Throughout the treatment, SNV promoted the expression of the anti-inflammatory cytokine interleukin-10 as well as neurotrophic factors commonly considered as beneficial in amyotrophic lateral sclerosis management (glial derived neuroptrophic factor, insulin like growth factor, brain derived neurotrophic factor).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502939.RAaG4A3rQJWHkKQaGt6Wmg4eLdFFztivI6oXWmRbAQ83Q130_provenance.
- NP502939.RAaG4A3rQJWHkKQaGt6Wmg4eLdFFztivI6oXWmRbAQ83Q130_assertion evidence source_evidence_literature NP502939.RAaG4A3rQJWHkKQaGt6Wmg4eLdFFztivI6oXWmRbAQ83Q130_provenance.
- NP502939.RAaG4A3rQJWHkKQaGt6Wmg4eLdFFztivI6oXWmRbAQ83Q130_assertion SIO_000772 25311268 NP502939.RAaG4A3rQJWHkKQaGt6Wmg4eLdFFztivI6oXWmRbAQ83Q130_provenance.
- NP502939.RAaG4A3rQJWHkKQaGt6Wmg4eLdFFztivI6oXWmRbAQ83Q130_assertion wasDerivedFrom befree-20150227 NP502939.RAaG4A3rQJWHkKQaGt6Wmg4eLdFFztivI6oXWmRbAQ83Q130_provenance.
- NP502939.RAaG4A3rQJWHkKQaGt6Wmg4eLdFFztivI6oXWmRbAQ83Q130_assertion wasGeneratedBy ECO_0000203 NP502939.RAaG4A3rQJWHkKQaGt6Wmg4eLdFFztivI6oXWmRbAQ83Q130_provenance.